$24.16
0.160.67%
Last update: Nov 6, 7:57 PM
Veracyte Inc
VCYTNASDAQ
Veracyte (VCYT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Veracyte (VCYT) last issued guidance on November 4, 2026 for fiscal year 2026. The company guided revenue in the range of $590M - $593M for the period.
Compared to prior guidance, Veracyte maintained its revenue forecast from a prior range of $590M - $596M.
Veracyte has issued 20 guidance updates between February 22, 2023 and November 4, 2026. During this period, the company raised its outlook 14 times and lowered it 2 times, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.38 | $0.41 | $0.31 | $0.36 |
| Actual | $0.51 | $0.54 | $0.52 | $0.53 |
| Surprise | +34.2% | +31.7% | +67.7% | +47.2% |
| Revenue | ||||
| Estimate | $147.2M | $144.3M | $130.4M | $136.9M |
| Actual | $151.8M | $150.3M | $139.1M | $140.6M |
| Surprise | +3.11% | +4.20% | +6.65% | +2.70% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.39 | $0.39 | $0.38 | $0.39 |
| Revenue | ||||
| Consensus | $153.1M | $152.0M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 4, 2026 | $0.51 | $0.38 | 34.2 % |
| Q2 | Jul 30, 2026 | $0.54 | $0.41 | 31.7 % |
| Q1 | May 5, 2026 | $0.52 | $0.31 | 67.7 % |
| Q4 | Feb 25, 2026 | $0.53 | $0.36 | 47.2 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 4, 2026 | $151.75M | $147.18M | 3.11 % |
| Q2 | Jul 30, 2026 | $150.32M | $144.27M | 4.20 % |
| Q1 | May 5, 2026 | $139.07M | $130.40M | 6.65 % |
| Q4 | Feb 25, 2026 | $140.64M | $136.94M | 2.70 % |
